Retinoic Acid Suppresses Growth of Lesions, Inhibits Peritoneal Cytokine Secretion, and Promotes Macrophage Differentiation in an Immunocompetent Mouse Model of Endometriosis
Overview
Affiliations
Objective: To determine the effects of all-trans-retinoic acid (RA) on establishment and growth of endometrial lesions, peritoneal interleukin-6 (IL-6) and macrophage chemotactic factor-1 (MCP-1) concentrations, and CD38, CD11b, and F4/80 expression on peritoneal macrophages in an immunocompetent mouse model of endometriosis.
Design: Experimental transplantation study using mice.
Setting: Academic medical center.
Animal(s): C57BL/6 recipient mice and syngeneic green fluorescent protein transgenic (GFP+) mice.
Intervention(s): Recipient mice were inoculated with GFP+ minced uterine tissue to induce endometriosis and treated with RA (400 nmol/day) or vehicle for 17 days (3 days before to 14 days after tissue injection).
Main Outcome Measure(s): Total number of GFP+ implants in recipient mice, number of implants showing visible blood vessels, total volume of established lesions per mouse, concentrations of IL-6 and MCP-1 in peritoneal fluid, and expression of CD11b, F4/80, and CD38 on peritoneal macrophages.
Result(s): Retinoic acid treatment for 17 days reduced the number of implants versus controls and decreased the frequency of lesions with vessels. Peritoneal washings in RA-treated animals had lower concentrations of IL-6 and MCP-1 than controls 3 days after endometrial inoculation and lower levels of IL-6 on day 14 after inoculation. Concomitant with these effects on day 14, CD38, CD11b, and F4/80 were higher on macrophages from RA-treated mice versus controls.
Conclusion(s): The development of endometriotic implants is inhibited by RA. This effect may be caused, at least in part, by reduced IL-6 and MCP-1 production and enhanced differentiation of peritoneal macrophages.
Zhao X, Zhao Y, Zhang Y, Fan Q, Ke H, Chen X J Biol Eng. 2024; 18(1):42.
PMID: 39061076 PMC: 11282767. DOI: 10.1186/s13036-024-00437-0.
Transgenic mice applications in the study of endometriosis pathogenesis.
Zhao Y, Wang Y, Gu P, Tuo L, Wang L, Jiang S Front Cell Dev Biol. 2024; 12:1376414.
PMID: 38933332 PMC: 11199864. DOI: 10.3389/fcell.2024.1376414.
Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis.
Chung M, Han S Front Glob Womens Health. 2022; 3:856316.
PMID: 35449709 PMC: 9016174. DOI: 10.3389/fgwh.2022.856316.
Endometriosis in the Mouse: Challenges and Progress Toward a 'Best Fit' Murine Model.
Burns K, Pearson A, Slack J, Por E, Scribner A, Eti N Front Physiol. 2022; 12:806574.
PMID: 35095566 PMC: 8794744. DOI: 10.3389/fphys.2021.806574.
Nunez-Badinez P, De Leo B, Laux-Biehlmann A, Hoffmann A, Zollner T, Saunders P Pain. 2021; 162(9):2349-2365.
PMID: 34448751 PMC: 8374713. DOI: 10.1097/j.pain.0000000000002248.